These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endophthalmitis After Clear Corneal Cataract Surgery: Outcomes Over Two Decades. Yannuzzi NA; Si N; Relhan N; Kuriyan AE; Albini TA; Berrocal AM; Davis JL; Smiddy WE; Townsend J; Miller D; Flynn HW Am J Ophthalmol; 2017 Feb; 174():155-159. PubMed ID: 27889501 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic intracameral cefazolin and postoperative topical moxifloxacin after cataract surgery: endophthalmitis risk reduction and safety results in a 16-year study. Moser CL; Lecumberri Lopez M; Garat M; Martín-Baranera M Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2185-2191. PubMed ID: 31392416 [TBL] [Abstract][Full Text] [Related]
5. TOXIC POSTERIOR SEGMENT SYNDROME AFTER DROPLESS CATARACT SURGERY WITH COMPOUNDED TRIAMCINOLONE-MOXIFLOXACIN. Patel SB; Reddy NK; He YG Retina; 2020 Mar; 40(3):446-455. PubMed ID: 30689622 [TBL] [Abstract][Full Text] [Related]
6. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Lalwani GA; Flynn HW; Scott IU; Quinn CM; Berrocal AM; Davis JL; Murray TG; Smiddy WE; Miller D Ophthalmology; 2008 Mar; 115(3):473-6. PubMed ID: 18067969 [TBL] [Abstract][Full Text] [Related]
7. International Practice Patterns for the Management of Acute Postsurgical and Postintravitreal Injection Endophthalmitis: European Vitreo-Retinal Society Endophthalmitis Study Report 1. Soliman MK; Gini G; Kuhn F; Iros M; Parolini B; Ozdek S; Michalewska Z; Bopp S; Adelman RA; Sallam AB; Ophthalmol Retina; 2019 Jun; 3(6):461-467. PubMed ID: 31043364 [TBL] [Abstract][Full Text] [Related]
8. Endophthalmitis after intravitreal injections versus cataract surgery: a 15-year cohort. Dar N; Pillar S; Friehmann A; Belkin A; Ofir S Int Ophthalmol; 2020 Jan; 40(1):73-79. PubMed ID: 31414274 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country - a one-year audit. Jeeva IK; Masud S; Siddiqui MAR J Pak Med Assoc; 2023 Jan; 73(1):92-97. PubMed ID: 36842015 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal moxifloxacin injections in acute post-cataract surgery endophthalmitis: Efficacy and safety. Agarwal A; Nagpal M Indian J Ophthalmol; 2021 Feb; 69(2):326-330. PubMed ID: 33463584 [TBL] [Abstract][Full Text] [Related]
11. Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis. Kowalski RP; Romanowski EG; Shanks RMQ; Mammen A; Dhaliwal DK Eye Contact Lens; 2018 Nov; 44 Suppl 2():S338-S343. PubMed ID: 29944493 [TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of cataract surgery complicated by endophthalmitis. Zhu J; Pi Y; Guo Q; Li Z Eye Sci; 2012 Sep; 27(3):147-51. PubMed ID: 22993061 [TBL] [Abstract][Full Text] [Related]
13. A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics. Manning S; Ugahary LC; Lindstedt EW; Wubbels RJ; van Dissel JT; Jansen JTG; Gan I; van Goor AT; Bennebroek CA; van der Werf DJ; Ossewaarde-van Norel A; Mayland Nielsen CC; Tilanus M; van den Biesen PR; Schellekens PA; La Heij E; Faridpooya K; van Overdam K; Veckeneer M; van Meurs JC Acta Ophthalmol; 2018 Jun; 96(4):348-355. PubMed ID: 29214740 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review. Tyson SL; Bailey R; Roman JS; Zhan T; Hark LA; Haller JA Curr Opin Ophthalmol; 2017 Jan; 28(1):73-80. PubMed ID: 27653606 [TBL] [Abstract][Full Text] [Related]
15. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. Pijl BJ; Theelen T; Tilanus MA; Rentenaar R; Crama N Am J Ophthalmol; 2010 Mar; 149(3):482-7.e1-2. PubMed ID: 20053391 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of intravitreal triamcinolone acetonide-moxifloxacin versus standard perioperative eyedrops in cataract surgery. Nassiri S; Hwang FS; Kim J; LeClair B; Yoon E; Pham M; Rauser ME J Cataract Refract Surg; 2019 Jun; 45(6):760-765. PubMed ID: 30850125 [TBL] [Abstract][Full Text] [Related]
17. Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: Results from 2 million consecutive cataract surgeries. Haripriya A; Chang DF; Ravindran RD J Cataract Refract Surg; 2019 Sep; 45(9):1226-1233. PubMed ID: 31371152 [TBL] [Abstract][Full Text] [Related]
18. Acute endophthalmitis after 25-gauge sutureless vitrectomy. Acar N; Unver YB; Altan T; Kapran Z Int Ophthalmol; 2007 Dec; 27(6):361-3. PubMed ID: 17492400 [TBL] [Abstract][Full Text] [Related]
19. Cataract surgery after intravitreal injection of triamcinolone acetonide. Jonas JB; Kreissig I; Degenring RF Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430 [TBL] [Abstract][Full Text] [Related]
20. Suspected bacterial endophthalmitis following sustained-release dexamethasone intravitreal implant: a case report. Arıkan Yorgun M; Mutlu M; Toklu Y; Cakmak HB; Cağıl N Korean J Ophthalmol; 2014 Jun; 28(3):275-7. PubMed ID: 24882964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]